Expertise in
3
conditions

Dr. Charles R. Dibb

Internal Medicine
Hematology Oncology Pharmacy
2828 E Barnett Rd, 
Medford, OR 
Expertise in
3
conditions
Hematology Oncology Pharmacy
2828 E Barnett Rd, 
Medford, OR 

Overview

Charles Dibb is a primary care provider, practicing in Internal Medicine in Medford, Oregon.

Dr. Dibb is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin Lymphoma, Breast Cancer, and Hemolytic-Uremic Syndrome.

He is actively involved in clinical research, participating in 4 clinical trials.

Specialties

Internal Medicine

Licenses

Internal Medicine in OR

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Hematology Oncology Pharmacy
2828 E Barnett Rd, Medford, OR 97504

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Randomized, Double-Blind Phase III Study of Pazopanib vs. Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease Following Metastatectomy
Randomized, Double-Blind Phase III Study of Pazopanib vs. Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease Following Metastatectomy
Enrollment Status: Active_not_recruiting
Publish Date: August 10, 2026
Intervention Type: Procedure, Drug, Other
Study Drug: Pazopanib Hydrochloride
Study Phase: Phase 3
A Randomized Phase II/III Trial of Afatinib Plus Cetuximab Versus Afatinib Alone in Treatment-Naive Patients With Advanced, EGFR Mutation Positive Non-small Cell Lung Cancer (NSCLC)
A Randomized Phase II/III Trial of Afatinib Plus Cetuximab Versus Afatinib Alone in Treatment-Naive Patients With Advanced, EGFR Mutation Positive Non-small Cell Lung Cancer (NSCLC)
Enrollment Status: Completed
Publish Date: May 18, 2026
Intervention Type: Drug, Other, Biological
Study Drugs: Afatinib Dimaleate, Cetuximab
Study Phase: Phase 2/Phase 3
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: May 06, 2026
Intervention Type: Drug, Other
Study Drugs: Carboplatin, Cyclophosphamide, Doxorubicin Hydrochloride, Paclitaxel
Study Phase: Phase 3
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: February 10, 2026
Intervention Type: Drug, Other
Study Drugs: Anastrozole, Everolimus, Exemestane, Goserelin Acetate, Letrozole, Leuprolide Acetate, Tamoxifen Citrate
Study Phase: Phase 3
View 3 Less Clinical Trials
Similar Doctors
Expertise in
28
conditions
Dr. Albert H. Newton-Iii
Internal Medicine
Expertise in
28
conditions
Dr. Albert H. Newton-Iii
Internal Medicine
Before you request

Office

2900 Doctors Park Dr Ste 200, 
Medford, OR 
 (0.2 miles away)
541-282-2200
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Albert Newton-Iii is a primary care provider, practicing in Internal Medicine in Medford, Oregon. Dr. Newton-Iii is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Hypothyroidism, Obesity in Children, Lipogranulomatosis, and Lipoid Proteinosis. Dr. Newton-Iii is currently accepting new patients.

Expertise in
15
conditions
Dr. Susan E. Kohler
Internal Medicine
Expertise in
15
conditions
Dr. Susan E. Kohler
Internal Medicine

Hematology Oncology Pharmacy

2828 E Barnett Rd, 
Medford, OR 
 (0.1 miles away)
541-774-5853
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Susan Kohler is a primary care provider, practicing in Internal Medicine in Medford, Oregon. Dr. Kohler is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Thrombocytopenia, Gaucher Disease Type 2, and Gaucher Disease Type 3. Dr. Kohler is currently accepting new patients.

Expertise in
9
conditions
Dr. Christopher M. Murphy
Internal Medicine
Expertise in
9
conditions
Dr. Christopher M. Murphy
Internal Medicine

Office

2900 Doctors Park Dr Ste 200, 
Medford, OR 
 (0.2 miles away)
541-282-2200
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Christopher Murphy is a primary care provider, practicing in Internal Medicine in Medford, Oregon. Dr. Murphy is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Hypothyroidism, Obesity in Children, Familial Combined Hyperlipidemia, and Xanthoma. Dr. Murphy is currently accepting new patients.

Frequently Asked Questions about Dr. Charles R. Dibb

How do I make an appointment with Dr. Charles R. Dibb?

You can book an appointment with Dr. Charles R. Dibb by calling their office at 541-774-5853. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Charles R. Dibb a top-rated expert for Chronic Lymphocytic Leukemia (CLL)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Charles R. Dibb is classified as an Advanced expert for Chronic Lymphocytic Leukemia (CLL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Charles R. Dibb specialize in?

While Dr. Charles R. Dibb is a Internal Medicine, they have specific expertise in Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin Lymphoma, and Breast Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Dibb's expertise for a condition
ConditionClose
      View All 33 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile